Astralis has begun Phase I clinical trial for Psoraxine for the treatment of moderate plaque psoriasis.
Derm In The News: September 17-23
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
CeraVe Partners With George Washington University to Expand Residency Training Program
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Combination Treatments in HS Require Further Review
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management
2 Clarke Drive Cranbury, NJ 08512